Antiviral Activity of Angelica Tenuissima Nakai against Influenza A Virus
Pathogens · 2024
DOI: 10.3390/pathogens13090761 ↗Kurz gefasst
Fachartikel in der Zeitschrift Pathogens, 2024. Verfasst von Won-Jong Park und 2 weiteren Autor:innen. Beteiligte Einrichtung: Department of Oral and Maxillofacial Surgery, Seoul St. Mary's Hospital, College of Medicine, The Catholic University of Korea, Seoul 06591, Republic…. Hauptthemen laut MEDLINE: Antiviral Agents, Angelica, Influenza A Virus, H1N1 Subtype, Plant Extracts. Die Arbeit nennt 28 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: National Research Foundation of Korea.
Abstract (Originalsprache)
The influenza A virus poses a serious threat to human health and is an important global public health issue. The drugs currently used for treatment are becoming increasingly ineffective against influenza A viruses and require the development of new antiviral drugs. Angelica tenuissima Nakai (ATN), a traditional herbal medicine belonging to the Umbelliferae family, exhibits a broad range of pharmacological activities, including inflammation, headache, and cold symptoms. In the present study, based on target protein identification, functional enrichment analysis, and gene set comparisons, we first suggested that ATN has potential therapeutic effects against influenza A virus infection. Next, methylthiazol tetrazolium (MTT) and sulforhodamine B colorimetric (SRB) assay results revealed that ATN exhibited low cytotoxicity in Madin–Darby canine kidney (MDCK) cells. The antiviral properties of ATN were observed against H1N1 and H3N2 virus strains. Microscopy confirmed the increased survival rate of the host cells. Further time-of-addition experiments revealed that the addition of ATN before virus adsorption showed similar results to the whole period of treatment. The pre- and co-treated groups showed lower levels of viral RNA (M1 protein). The results of this study suggest that ATN exhibits antiviral properties against the influenza A virus. These therapeutic properties of ATN can serve as a theoretical basis for further research on the applicability of ATN in the development of antiviral agents.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Oral and Maxillofacial Surgery, Seoul St. Mary's Hospital, College of Medicine, The Catholic University of Korea, Seoul 06591, Republic of Korea.
- Department of Pharmacology, School of Korean Medicine, Wonkwang University, Iksan 54538, Republic of Korea.
- Department of Oral Pharmacology, College of Dentistry, Wonkwang University, Iksan 54538, Republic of Korea.
ORCID-Profile: Won-Jong Park
Förderung
- National Research Foundation of Korea
Zitieren
APA
Park, W. J., Bae, G. S., & Han, Y. H. (2024). Antiviral Activity of Angelica Tenuissima Nakai against Influenza A Virus. Pathogens. https://doi.org/10.3390/pathogens13090761
Vancouver
Park WJ, Bae GS, Han YH. Antiviral Activity of Angelica Tenuissima Nakai against Influenza A Virus. Pathogens. 2024. doi:10.3390/pathogens13090761
BibTeX
@article{Park2024,
author = {Park, Won-Jong and Bae, Gi-Sang and Han, Youn-Ho},
title = {Antiviral Activity of Angelica Tenuissima Nakai against Influenza A Virus},
journal = {Pathogens},
year = {2024},
doi = {10.3390/pathogens13090761}
}
EUVIMED